Globus Medical (GMED) Total Current Liabilities (2011 - 2026)
Globus Medical (GMED) posted Total Current Liabilities of $482.5 million for Q1 2026, down 3.22% on a QoQ basis from $498.5 million in Q4 2025, and up 25.41% year-over-year from $384.7 million in Q1 2025.
Globus Medical (GMED) Total Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $482.5 million for Q1 2026.
- Quarterly Total Current Liabilities rose 25.41% year-over-year to $482.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $482.5 million (up 25.41% YoY) and the FY2025 annual result came in at $498.5 million, down 41.76% from the prior year.
- Total Current Liabilities was $482.5 million for Q1 2026 at Globus Medical, down from $498.5 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $855.9 million in Q4 2024 and bottomed at $141.5 million in Q1 2022.
- A 5-year average of $426.3 million and a median of $424.7 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 411.63% — and 2025, when it tumbled 51.08%.
- Globus Medical's Total Current Liabilities stood at $159.2 million in 2022, then surged by 146.44% to $392.3 million in 2023, then jumped by 118.15% to $855.9 million in 2024, then tumbled by 41.76% to $498.5 million in 2025, then decreased by 3.22% to $482.5 million in 2026.
- Business Quant data shows GMED's Total Current Liabilities at $482.5 million in Q1 2026, $498.5 million in Q4 2025, and $466.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn | 482.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 482.46 Mn |
| Dec 31, 2025 | 498.50 Mn |
| Sep 30, 2025 | 465.96 Mn |
| Jun 30, 2025 | 424.66 Mn |
| Mar 31, 2025 | 384.70 Mn |
| Dec 31, 2024 | 855.91 Mn |
| Sep 30, 2024 | 818.07 Mn |
| Jun 30, 2024 | 794.15 Mn |
| Mar 31, 2024 | 786.32 Mn |
| Dec 31, 2023 | 392.35 Mn |
| Sep 30, 2023 | 428.72 Mn |
| Jun 30, 2023 | 155.22 Mn |
| Mar 31, 2023 | 167.55 Mn |
| Dec 31, 2022 | 159.20 Mn |
| Sep 30, 2022 | 145.26 Mn |
| Jun 30, 2022 | 146.02 Mn |
| Mar 31, 2022 | 141.49 Mn |
| Dec 31, 2021 | 140.16 Mn |
| Sep 30, 2021 | 122.53 Mn |
| Jun 30, 2021 | 130.04 Mn |